title: Desquamative Dermatitis Caused by Erlotinib: An Underreported Cutaneous Adverse Event.
authors.affiliation: Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
authors.forename: Miriam L
authors.initials: ML
authors.lastname: Vega
authors.affiliation: Leonard M. Miller School of Medicine, University of Miami, Miami, FL.
authors.forename: Natalie C
authors.initials: NC
authors.lastname: Yin
authors.affiliation: Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; matthew.keller@jefferson.edu.
authors.forename: Matthew
authors.initials: M
authors.lastname: Keller
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D000069347:Erlotinib Hydrochloride / Q000009:adverse effects*; D006801:Humans
chemical_list: D000970:Antineoplastic Agents; D000069347:Erlotinib Hydrochloride